In light of Hurricane Michael’s destructive landfall Wednesday in the Florida panhandle, the American Heart Association is warning cardiovascular patients to plan ahead for unexpected emergencies, as they could be at an increased risk for CVD events during the storm.

E-cigarettes have been touted as a way to help people stop using combustible cigarettes, but a new analysis in the Annals of Internal Medicine estimates 1.9 million American adults who vape have never smoked tobacco cigarettes.

When ordering physicians overmanage an incidental pancreatic cyst detected at MRI, it can lead to higher downstream costs, according to a new study published in the American Journal of Roentgenology. What can radiologists do to improve adherence to their recommendations?

Researchers estimated the average downstream cost of incidental pancreatic cysts identified on MRI at $460 per finding, according to an Oct. 9 study published in the American Journal of Roentgenology. It may suggest a need for targeted efforts to promote greater guideline adherence.

There may still be a need for programs and interventions designed to reduce or eliminate cost barriers for some women who receive breast screening mammograms, according to new research published in the Journal of Women’s Health. Almost 40 percent of uninsured women aged 50-64 years old, for instance, reported paying out-of-pocket costs for their most recent mammogram. 

DenseBreast-info.org (DB-I), a New York state-based organization focused on providing education to patients and healthcare professionals regarding breast density, announced its expansion to Europe with the launch of a new website.

Wisconsin companies SHINE Medical Technologies and NorthStar Medical Radioisotopes will receive funds from the 2019 Energy & Water Development Appropriations Bill to develop a domestic source of medical isotopes—specifically, molybdenum-99 (Mo-99).

The deal Regeneron and Sanofi cut with Express Scripts to lower the prices of their PCSK9 inhibitor in exchange for simpler preauthorization forms has opened the floodgates for another two dozen such deals for the cholesterol-lowering drug class, the New York Times reported.